Evidence map›Paper›PMID 32359443›Full record

ArticleMolecular cell2020

BRCA1 Mutational Complementation Induces Synthetic Viability.

Joseph Nacson, Daniela Di Marcantonio, Yifan Wang, Andrea J Bernhardy, Emma Clausen, Xiang Hua, Kathy Q Cai, Esteban Martinez, Wanjuan Feng, Elsa Callén and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. TheBiomolecular NMR assignments · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Joseph NacsonMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Daniela Di MarcantonioBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Yifan WangMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Andrea J BernhardyMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Emma ClausenMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Xiang HuaBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Kathy Q CaiHistopathology Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Esteban MartinezBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Wanjuan FengDepartment of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Elsa CallénLaboratory of Genome Integrity, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
Wei WuLaboratory of Genome Integrity, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
Gaorav P GuptaDepartment of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Joseph R TestaCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
Stephen M SykesBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Neil JohnsonMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Electronic address: neil.johnson@fccc.edu.
Fox Chase Cancer Center · USNational Cancer Institute · USTemple University · USUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant CancersR01CA214799 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Neil Johnson · 2017 to 2026
$4.3M
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy ResistanceR01CA227830 · NCI · WASHINGTON UNIVERSITY · PI SYKES, STEPHEN MATTHEW · 2019 to 2023
$1.9M
The role of microhomology-mediated end joining in Fanconi anemia pathogenesisR01HL150190 · NHLBI · RESEARCH INST OF FOX CHASE CAN CTR · PI JOHNSON, NEIL · 2020 to 2023
$1.9M
NCI NIH HHS R01 CA214799NCI NIH HHS R01 CA227830NHLBI NIH HHS R01 HL150190
6 · The paper itself

Abstract

BRCA1 promotes the DNA end resection and RAD51 loading steps of homologous recombination (HR). Whether these functions can be uncoupled, and whether mutant proteins retaining partial activity can complement one another, is unclear and could affect the severity of BRCA1-associated Fanconi anemia (FA). Here we generated a Brca1

Indexed as

AnimalsBRCA1 ProteinDNA Breaks, Double-StrandedDNA RepairExonsFanconi AnemiaFemaleHEK293 CellsHomologous RecombinationHumansMaleMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutMutationBRCA1 ProteinBRCA1 protein, humanBrca1 protein, mouseRad51 RecombinaseTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID32359443
PMCPMC7418109
OpenAlexW3022272253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.